Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies. - Wikidata - awgldk - TriplyDB

Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies.

Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies.

http://www.wikidata.org/entity/Q38092053

about

Elevated risk of venous thromboembolic events in patients with inflammatory myopathies Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies Muscle biopsy features of idiopathic inflammatory myopathies and differential diagnosis Phenotype standardization for statin-induced myotoxicity Immunotherapies for Immune-Mediated Myopathies: A Current Perspective An overview of polymyositis and dermatomyositis.Analysis of autoantibodies to 3-hydroxy-3-methylglutaryl-coenzyme A reductase using different technologies.Drugs in induction and treatment of idiopathic inflammatory myopathies Myositis autoantibodies and clinical phenotypes.A case report of autoimmune necrotizing myositis presenting as dysphagia and neck swelling.Statins and myotoxic effects associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: an observational study in Japan.Anti-HMGCR antibodies in systemic sclerosis An Unusual Case of Statin-Induced Myopathy: Anti-HMGCoA Necrotizing Autoimmune Myopathy Pure White Cell Aplasia and Necrotizing Myositis The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomes Persisting weakness after withdrawal of a statin.Statin intolerance: diagnosis and remedies.Immune-Mediated Necrotizing Myopathy: Update on Diagnosis and Management.Immune-mediated statin myopathy.Use of Statins to Augment Progenitor Cell Function in Preclinical and Clinical Studies of Regenerative Therapy: a Systematic Review.Diagnostic criteria for inclusion body myositis.Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase increases the expression of interferon-responsive genes.HMGCR-associated myositis: a New Zealand case series and estimate of incidence.A severe myopathy case in aged patient treated with high statin dosage.Does reduced creatine synthesis protect against statin myopathy?Adaptive immune response to therapy in hmgcr autoantibody myopathy.[Leg pain].Isolated gluteal and paravertebral muscle weakness due to anti-HMGCR antibody-associated necrotizing autoimmune myopathy.Diagnostic confounders of chronic widespread pain: not always fibromyalgia.Statin-associated muscle symptoms: position paper from the Luso-Latin American Consortium.Statin-induced necrotizing autoimmune myopathy: importance of early recognition.[Myositides: What is the current situation?].

P2860

Q26746904-0910A5F8-5C15-47E7-9BDE-0B9B6D08E6B1 Q26863125-01A20846-823F-4A2E-8975-B43B01D7CF17 Q26991722-57D0384F-958E-4C80-8047-410ED0360EAA Q27020935-BA4260EC-30FD-4124-8D9B-CAE085BAF909 Q30699742-8888C667-73A5-4FEA-A3BB-B3F4BB09F8DB Q34667765-4ABF178C-80B5-4F4E-BD1D-155A8A87EF58 Q35151003-8F47FDD9-A527-4FC5-9240-CE11D226C52A Q35281940-B0442647-CC7A-4ACC-A553-A3AD0BA050C5 Q35281962-9C0EC875-96D3-475F-A293-7FD0A3758CE4 Q36020670-84A3739F-F784-42DE-8423-54F0A7516F7B Q36153401-5CF89324-E597-477C-AB6E-B8E9CAFAA80D Q36196309-E51AAD68-CE64-4B62-BBC8-110AEA731BFE Q36258444-33F6CC37-CFB7-4FF4-ABB6-5F10DFBB18F5 Q36747683-DE246189-32AE-4B65-8FC3-CC0362BB92F4 Q37022721-F9493F5D-6752-4923-9529-CBDC5152200E Q37704222-C35E2891-8F14-406E-99D9-CAB2743BF366 Q38430744-E432B9D9-43AE-40B9-BDC7-6AEFA777B628 Q38619882-EEFA09D6-8657-4F69-A08A-2BBB0CB24D9A Q38619946-5B625917-4B62-4BBB-AAED-EBD908F3D363 Q38731697-D5674440-0673-49F2-9250-3E9C7FA01E05 Q38793315-5D95F269-0EC8-4D59-BAD2-B3776513AB29 Q38966882-0304A576-A24D-4752-8240-43498210F318 Q40758505-89711F99-A575-447B-8827-263E49D2C5F3 Q41678852-B7F5D755-B7B0-4D0C-90AF-56E7CD4F3EA4 Q41886705-8DAE53E2-9C40-41AB-8F18-9F04C660681A Q43079949-F335190A-FE26-4A8A-890A-52F92D098461 Q43486981-DC4115EA-D314-43BB-BA82-A34E374A7455 Q47442990-460D1531-FAE9-4D79-B3BD-35066AD95C42 Q47552826-E3577E9A-0980-4F4E-9AE5-0829AC7B06D0 Q51752364-713C4485-5F09-4AB7-A719-1B62A537B0FE Q52859885-42FFB51E-118A-45A7-A13A-5FF6B282F42B Q54258621-418EF20F-6AFC-4CE9-92DB-D22E5EC976C4

P2860

Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies.

http://www.wikidata.org/entity/Q38092053

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies.

@en

type

label

Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies.

@en

prefLabel

Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies.

@en

P1433

Q38092053-01EFEFC4-E7A3-44CA-B8F3-CE8903E96453

P1476

Q38092053-C63AEB86-DB9C-4D01-9311-54DD315A162F

P2093

Q38092053-6D09EAF7-C63D-4D3E-851E-B4AAF824B704

P2860

Q38092053-03252032-2549-4B84-9060-592AF9E93E9E

Q38092053-0CBE3B9B-6F45-4884-9B91-EB521548877A

Q38092053-17E3C3B0-FE25-4A6D-B38E-48B0A4685D77

Q38092053-1934848C-2C5E-40F4-9DB5-3FEFE1BC8C26

Q38092053-1FD9091A-3757-46A8-8F74-307B0329B331

Q38092053-251D407D-00EB-45C7-B5C6-CB3938521EBF

Q38092053-3AD43B61-FD21-414A-A8C1-2B5B66783B4C

Q38092053-3CD1AC14-6A34-4000-8817-47F9CAF718DC

Q38092053-3D3FB377-0753-4141-B99D-89C589364967

Q38092053-3F23BB77-0338-435A-8549-F0D0C32150B3

P304

Q38092053-3275AE57-9F4C-4DCB-95B6-9C6997CC771B

P31

Q38092053-B9E426E1-5AF1-4D03-B1E2-94A60EBD9C4E

P356

Q38092053-9A2855DC-7A09-4041-B0BA-590AE5547017

P433

Q38092053-6E53DE1D-8798-4EFC-8622-E2B23B144637

P478

Q38092053-D1B55F48-F517-43D7-B925-DFDB25EC9EBC

P50

Q38092053-F06D3E38-F967-49CB-8463-037BB2CF2BCA

P577

Q38092053-D8DCC760-0D1F-42BC-89A7-8FA49469986C

P698

Q38092053-AA3430B3-A256-444A-AEF6-DE8EEEC3EE37

P921

Q38092053-01ADEB86-E17B-48AC-89D0-433E2260241F

P356

P1433

Muscle and Nerve

P1476

Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies

@en

P2093

Andrew L Mammen

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic determinants of statin intolerance

Association between statin-associated myopathy and skeletal muscle damage

Statin induced myopathy and myalgia: time trend analysis and comparison of risk associated with statin class from 1991-2006

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials

SLCO1B1 variants and statin-induced myopathy--a genomewide study

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

HMG-CoA reductase inhibitors and myotoxicity.

Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls.

Statin-associated myopathy with normal creatine kinase levels.

P304

477-483

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MUS.23854

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-08-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23519993

http://www.w3.org/2001/XMLSchema#string

P921